Thymic adenocarcinoma presenting as an incidental mediastinal mass

被引:0
作者
O'Shea, Anne E. [1 ]
Nissen, Alexander P. [1 ]
Bowen, Donnell K. [2 ]
Barnett, Taylor L. [3 ]
Gustafson, Joshua D. [2 ]
机构
[1] San Antonio Mil Med Ctr, Dept Surg, Ft Sam Houston, TX USA
[2] San Antonio Mil Med Ctr, Div Cardiothorac Surg, 3551 Roger Brooke Dr, Ft Sam Houston, TX 78234 USA
[3] San Antonio Mil Med Ctr, Div Hematol & Oncol, Ft Sam Houston, TX USA
关键词
Thymus; Thymic adenocarcinoma; Thymectomy; Acute myeloid leukemia; CLASSIFICATION; CHEMOTHERAPY;
D O I
10.1186/s13019-022-02000-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Primary thymic adenocarcinoma represents an exceptionally rare malignancy, for which the cornerstone of therapy is margin-negative resection, with radiation and systemic therapy reserved for invasive and advanced disease. Thymic adenocarcinoma has not been previously reported in the setting of a concomitant malignancy, as reported herein. Case presentation We present a case of a 55-year-old previously healthy male diagnosed with acute myeloid leukemia, also found to have a mediastinal mass. Evaluation of the mediastinal mass with tumor markers, biopsies, and next-generation sequencing proved non-diagnostic, while he was simultaneously treated with induction chemotherapy to prevent leukemia-related blast crisis. After completing and recovering from induction chemotherapy, he underwent successful thymectomy during a chemotherapy holiday, with a margin-negative resection of thymic adenocarcinoma. He has subsequently recovered and undergone successful allogeneic hematopoietic stem cell transplant. Conclusions We present a case of synchronous adult acute myeloid leukemia and primary thymic adenocarcinoma requiring a tailored approach for management of simultaneous malignancies.
引用
收藏
页数:4
相关论文
共 5 条
[1]   The Masaoka-Koga Stage Classification for Thymic Malignancies Clarification and Definition of Terms [J].
Detterbeck, Frank C. ;
Nicholson, Andrew G. ;
Kondo, Kazuya ;
Van Schil, Paul ;
Moran, Cesar .
JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (07) :S1710-S1716
[2]   Primary adenocarcinoma of the thymus: an immunohistochemical and molecular study with review of the literature [J].
Maghbool, Maryam ;
Ramzi, Mani ;
Nagel, Inga ;
Bejarano, Pablo ;
Siebert, Reiner ;
Saeedzadeh, Abolfazl ;
Daneshbod, Yahya .
BMC CLINICAL PATHOLOGY, 2013, 13
[3]   The 2021 WHO Classification of Tumors of the Thymus and Mediastinum: What Is New in Thymic Epithelial, Germ Cell, and Mesenchymal Tumors? [J].
Marx, Alexander ;
Chan, John K. C. ;
Chalabreysse, Lara ;
Dacic, Sanja ;
Detterbeck, Frank ;
French, Christopher A. ;
Hornick, Jason L. ;
Inagaki, Hiroshi ;
Jain, Deepali ;
Lazar, Alexander J. ;
Marino, Mirella ;
Marom, Edith M. ;
Moreira, Andre L. ;
Nicholson, Andrew G. ;
Noguchi, Masayuki ;
Nonaka, Daisuke ;
Papotti, Mauro G. ;
Porubsky, Stefan ;
Sholl, Lynette M. ;
Tateyama, Hisashi ;
Montpreville, Vincent Thomas de ;
Travis, William D. ;
Rajan, Arun ;
Roden, Anja C. ;
Stroebel, Philipp .
JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (02) :200-213
[4]   Clinical outcomes with chemotherapy for advanced thymic carcinoma [J].
Okuma, Yusuke ;
Hosomi, Yukio ;
Takagi, Yusuke ;
Sasaki, Eisaku ;
Hishima, Tsunekazu ;
Maeda, Yoshiharu ;
Shibuya, Masahiko ;
Okamura, Tatsuru .
LUNG CANCER, 2013, 80 (01) :75-80
[5]   Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a FLT3 Mutation [J].
Stone, R. M. ;
Mandrekar, S. J. ;
Sanford, B. L. ;
Laumann, K. ;
Geyer, S. ;
Bloomfield, C. D. ;
Thiede, C. ;
Prior, T. W. ;
Doehner, K. ;
Marcucci, G. ;
Lo-Coco, F. ;
Klisovic, R. B. ;
Wei, A. ;
Sierra, J. ;
Sanz, M. A. ;
Brandwein, J. M. ;
de Witte, T. ;
Niederwieser, D. ;
Appelbaum, F. R. ;
Medeiros, B. C. ;
Tallman, M. S. ;
Krauter, J. ;
Schlenk, R. F. ;
Ganser, A. ;
Serve, H. ;
Ehninger, G. ;
Amadori, S. ;
Larson, R. A. ;
Doehner, H. .
NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (05) :454-464